Contents
- Whereas a provision of the annexed Regulations deals with…
- Interpretation
- Part 1 Class A Precursors
- Part 2 Class B Precursors
- Part 3 General Provisions
- Part 4 Pharmacists, Practitioners and Hospitals
- Transitional and Coming into Force
- (Paragraph 5(b), section 8, subsections 9(1.1), clause 91.1(1)(d)(iii)(B), subsection 91.3(1), section 91.9, subsection 91.92(1), paragraph 91.96(2)(b) and section 92)
Whereas a provision of the annexed Regulations deals with the communication of information obtained under the Regulations to certain classes of persons, and in the opinion of the Governor in Council, pursuant to paragraph 55(1)(s) of the Controlled Drugs and Substances Act, it is necessary to communicate the information to those classes of persons for the proper administration of the Act and the Regulations;Therefore, Her Excellency the Governor General in Council, on the recommendation of the Minister of Health, pursuant to subsection 55(1) of the Controlled Drugs and Substances Act, hereby makes the annexed Precursor Control Regulations.note
Interpretation
1#
Part 1 · Class A Precursors
Exemption
2#
3#
4#
5#
Limitation on Activities
6#
6.1#
Conditions Applicable to Licensed Dealers
7#
End-use Declaration
8#
Limitation on Transportation
9.1#
10#
Authorization Concerning Preparations and Mixtures
10.1#
Individuals
11#
Licence
Eligibility for a Licence
Senior Person in Charge and Responsible Person in Charge
13#
Application for a Licence
14#
Additional Information
Pre-licence Inspection
15.1#
Issuance of Licence
16#
Grounds for Refusal
17#
Expiration
Amendment of Licence
19#
Amendment of Application Information
20#
21#
Revocation or Suspension of Licence
23#
24#
Importation
Application for Import Permit
25#
Issuance of Import Permit
26#
Grounds for Refusal
27#
Surrender of Import Permit
28#
Declaration
28.1#
Revocation or Suspension of Permit
29#
30#
31#
Exportation
Application for Export Permit
32#
Issuance of Export Permit
33#
Grounds for Refusal
34#
Surrender of Export Permit
35#
Declaration
35.1#
Revocation or Suspension of Permit
36#
37#
38#
In Transit and Transhipment
Issuance of a Permit for Transit or Transhipment
40#
Grounds for Refusal
41#
Surrender of Permit
42#
Notice of Transit or Transhipment
43#
Revocation or Suspension of Permit
44#
45#
46#
Destruction
47#
Preparations and Mixtures
Application for Authorization Certificate
48#
Issuance of Authorization Certificate
49#
Document Accompanying Shipment
51#
Revocation or Suspension of Certificate
54#
Part 2 · Class B Precursors
Exemption
56#
Limitation on Activities
57#
Authorization Concerning Preparations and Mixtures
57.1#
Registration
Eligibility
58#
59#
Application
60#
Additional Information
Registration and Certificate
62#
Grounds for Refusal
63#
Length of Validity
64#
Notice of Change of Information
65#
Revocation or Suspension
67#
68#
Export
Application for Export Permit
69#
Issuance of Export Permit
70#
Grounds for Refusal
71#
Surrender of Export Permit
72#
Declaration
72.1#
Revocation or Suspension of Permit
73#
74#
Preparations and Mixtures
Application for Authorization Certificate
76#
Issuance of Authorization Certificate
77#
Document Accompanying Shipment
79#
Revocation and Suspension
82#
Part 3 · General Provisions
Restricted Access to Class A Precursors
83#
Books, Registers, Electronic Data and Other Records
85#
Suspicious Transactions
86#
Annual Report
87#
87.1#
Notice of Precursor Removal
87.2#
Unauthorized Changes
88#
Return of Documents
89#
Disclosure of Information by the Minister
91#
Part 4 · Pharmacists, Practitioners and Hospitals
Pharmacists
Activities Authorized Under a Prescription
91.2#
91.3#
Information to Be Recorded
91.4#
91.5#
Refill of Prescription
91.6#
Transfer of Prescription
91.7#
Practitioners
91.8#
91.9#
Hospitals
91.91#
91.92#
91.93#
91.94#
Transitional and Coming into Force
Transitional
92#
Coming into Force
93#
(Paragraph 5(b), section 8, subsections 9(1.1), clause 91.1(1)(d)(iii)(B), subsection 91.3(1), section 91.9, subsection 91.92(1), paragraph 91.96(2)(b) and section 92)
| Column 1 | Column 2Item | Substance | Maximum Quantity (expressed as an absolute amount or per package)1 | Acetic anhydride | 1000 kg2 | N-Acetylanthranilic acid (2-acetamidobenzoic acid) | 1 kg3 | Anthranilic acid (2-aminobenzoic acid) | 1 kg4 | Ephedra | 20 g per package5 | Ephedrine (erythro-2-(methylamino)-1-phenyl-propan-1-ol) | 0.4 g per package6 | Ergometrine (9,10-didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8-carboxamide) | 07 | Ergotamine (12′-hydroxy-2′-methyl-5′-(phenylmethyl)ergotaman-3′,6′,18-trione) | 08 | Isosafrole (5-(1-propenyl)-1,3-benzodioxole) | 0.5 kg9 | Lysergic acid (9,10-didehydro-6-methylergoline-8-carboxylic acid) | 010 | 3,4-Methylenedioxyphenyl-2- propanone (1-(1,3- benzodioxole)-2-propanone), its derivatives and analogues and salts of derivatives and analogues, including:(1)methyl 3-(1,3-benzodioxol-5-yl)-2-methyloxirane-2-carboxylate (MMDMG) | 011 | Norephedrine (Phenylpropanolamine) | 012 | Phenylacetic acid | 1 kg13 | 1-Phenyl-2-propanone, its derivatives and analogues and salts of derivatives and analogues, including:(1)methyl 2-methyl-3-phenyloxirane-2-carboxylate (BMK methyl glycidate)(2)3-oxo-2-phenylbutanamide (alpha-phenylacetoacetamide-APAA) | 014 | Piperidine | 0.5 kg15 | Piperonal (1,3-benzodioxole-5-carboxaldehyde) | 0.5 kg16 | Potassium permanganate | 50 kg17 | Pseudoephedrine (threo-2-(methylamino)-1-phenyl-propan-1-ol) | 3 g per package18 | Safrole (5-(2-propenyl)-1,3-benzodioxole) | 0.25 kg19 | Gamma-butyrolactone (dihydro-2(3H)- furanone) | 020 | 1,4-butanediol | 021 | Red Phosphorus | 022 | White Phosphorus | 023 | Hypophosphorous acid, its salts and derivatives | 024 | Hydriodic acid | 025 | Alpha-phenylacetoacetonitrile and its salts, isomers and salts of isomers | 026 | Propionyl chloride | 027 | 1-Phenethyl-4-piperidone and its salts | 028 | 4-Piperidone (piperidin-4-one), its salts, derivatives and analogues and salts of derivatives and analogues, including:(1)1-boc-4-piperidone (tert-butyl 4-oxopiperidine-1-carboxylate)(2)3-methyl-4-piperidone (3-methylpiperidin-4-one)(3)1-benzyl-4-piperidone (1-benzylpiperidin-4-one) | 029 | Norfentanyl (N-phenyl-N-piperidin- 4-ylpropanamide), its salts, derivatives and analogues and salts of derivatives and analogues | 030 | 1-Phenethylpiperidin-4-ylidenephenylamine and its salts | 031 | N-Phenyl-4-piperidinamine (N-phenylpiperidin-4-amine), its salts, derivatives and analogues and salts of derivatives and analogues, including:(1)4-anilino-1-boc-piperidine (tert-butyl 4-(phenylamino)piperidine-1-carboxylate)(2)4-fluoro anilino-1-boc-piperidine (tert-butyl 4-((4-fluorophenyl)amino)piperidine-1-carboxylate)(3)N-(4-fluorophenyl)-4-piperidinamine (N-(4-fluorophenyl)piperidin-4-amine)(4)4-bromo anilino-1-boc-piperidine (tert-butyl 4-((4-bromophenyl)amino)piperidine-1-carboxylate) | 032 | N1,N1,N2-trimethylcyclohexane-1,2-diamine and its salts | 033 | Benzylfentanyl (N-(1-benzylpiperidin-4-yl)-N-phenylpropionamide), its salts, derivatives and analogues and salts of derivatives and analogues | 034 | Phenethyl bromide ((2-bromoethyl)benzene) | 035 | Propionic anhydride (propanoic anhydride) | 036 | Phenethyl iodide ((2-iodoethyl)benzene) | 037 | Phenethyl chloride ((2-chloroethyl)benzene) | 038 | R 29676 (5-chloro-1-(piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one) and its salts | 0
Federal laws of Canada reproduced under the Reproduction of Federal Law Order (SI/97-5); not the official version. Source: Justice Laws Website.